An open-label, randomized, three-period, six-sequence crossover study to evaluate bioequivalence of three olanzapine containing tablet formulations in health subjects.
Phase of Trial: Phase III
Latest Information Update: 11 Nov 2016
At a glance
- Drugs Olanzapine/samidorphan (Primary) ; Olanzapine
- Indications Schizophrenia
- Focus Pharmacokinetics
- 11 Nov 2016 New trial record